invest selangor

MEDICALLY REVIEWED

Teplizumab: Monoclonal Antibody Treatment for T1DM that was recently approved by FDA

Teplizumab is a CD3-directed monoclonal antibody (mAb) that is a genetically modified derivative of the CD3-directed murine OKT3 mAb.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

covid-19 booster asia
Should I Get a COVID-19 Booster Shot? Experts from Asia Weigh In

Dr. Silverose Ann Bacolcol, Head of Manila Doctors’ Hospital Infection Prevention and Control Office, shared that “Most of the COVID-19 cases we see now are mild to moderate infections and can be managed at home. However, patients who have risk factors for disease progression, such as the elderly, those with co-morbid conditions, and are immunocompromised, need close monitoring and may have to be admitted.”

Dr Bacolcol strongly advised to receive a booster shot. She stated, “people should still receive their booster shots for COVID-19 because the threat of COVID-19 infection still exists and will continue to stay. The US CDC and Philippine DOH recommend the COVID-19 booster to prevent serious illness, hospitalisation, and death due to COVID-19.” About 23 million Filipinos have received a booster shot.

Read More »
Shingles Rash
Shingles: Adult Chickenpox?

Shingles, also known as herpes zoster, is a painful rash caused by varicella zoster virus (VZV), the same virus responsible for Chickenpox. After recovery from Chickenpox, VZV

Read More »